Diversity And Inclusion

The aim of Pathways: Inclusivity in Dermatology is to increase diversity among practicing dermatologists, one student at a time.

True progress in achieving a diverse and equitable rheumatology workforce will require honest conversations regarding the impacts of racism and bias, according to a presenter at the 2023 AWIR annual conference.

In the latest installment of our diversity, equity and inclusion video series with ASGE, Anna H. Owings, DO, discusses racial disparities in treatment initiation and response in patients with inflammatory bowel disease.

Oncologists are trained to notice signs others miss. A cough. A patch of rough skin. A feeling of fatigue. However, there is one concern that is often unnoticed by men within our own profession: Gender discrimination.

The current racial and ethnic landscape of academic dermatology leadership is not reflective of students and patients, according to a study.

Despite the fact that Black individuals routinely demonstrate the highest prevalence rates for lupus — with frequencies two to three times that of white individuals — they still account for just 14% of clinical trial participants.

The American Psychiatric Association released a statement condemning the Supreme Court’s ruling declaring that race cannot be a factor in university admissions. The Supreme Court on June 29 ruled 6-3 that admissions programs at Harvard University and the University of North Carolina-Chapel Hill that relied partly on race considerations were unconstitutional.

SAN DIEGO — People from underrepresented racial and ethnic groups participate in clinical trials at extremely low rates, and trialists have a duty to ensure participants reflect the larger community, according to a speaker.

WASHINGTON — A panel of optometrists here at Optometry’s Meeting urged their colleagues to provide mentorship and practice inclusion in their eye clinics.

A networking group created for cardiology fellows-in-training has successfully engaged trainees with clinical trial programs, serving as a model to help diversify recruitment and representation in trials, researchers reported.